Breakthrough technology opens the door to identifying new drug targets that could treat many genetic diseases. Scientists at the Gladstone Institutes have invented a new way to read and interpret the human genome. The computational method, TargetFinder, can predict where non-coding DNA-the DNA that does not code for proteins – interacts with genes. This technology helps researchers connect mutations in the so-called genomic “dark matter” with the genes they affect, potentially revealing new therapeutic targets for genetic disorders. Influence of features by region.
(a,b) Fe...
Recent Comments